期刊文献+

血液灌流串联血液透析治疗慢性肾功能衰竭的临床观察 被引量:2

The clinical study of combined Hemoperfusion + hemodialsi in chronic renal failure
原文传递
导出
摘要 目的 探讨血液灌流串联血液透析(HP+HD)治疗慢性肾功能衰竭的疗效和安全性。方法维持性血液透析患者34例,采用血液灌流串联血液透析(HP+HD)治疗方法与常规血液透析(HD)方法(自身对照)。治疗前后检测中分子物质(MMS)、血尿酸、肌酐、白蛋白、血细胞及临床症状。结果血液灌流治疗血液透析患者能显著清除慢性肾功能衰竭患者体内的中分子物质,单次使用治疗2hMMS平均下降25.0%,最高达44.4%。而普通透析对MMS无多大影响,两者具有显著性差异(P〈0.01)同时患者的睡眠、食欲、皮肤瘙痒有不同程度的改善。未发生其他任何不良事件和副作用。结论作为MMS的清除治疗措施,血液灌流临床使用安全、疗效可靠、无毒副反应。 Objective To investigate the effect and safety of combined hemodialysis-resin hemoperf usion in ehroicuremia. Methods 34 patinets with chronic uremia were treated by combined hemodialysis-resin hemoperfusion. Middle molecular substances ( MMS), urea and ereatinine were detcted before and after the treatment. Meanwhile ,we compared the effect of combined hemodialysis-resin hemoperfusion procdure with conventional hemodialysis in uremic toxin clearance. Results MMS was reduced significantly in combined hemodialy- sis-hemoperfusion procedure( P 〈0.01 ). Compared with conventional hemoodialysis ,a combination of hemoperfusion and hemodialysis had a better effect in MMS clearance (P 〈 0. 01 ). Meanwhile, some clinical conditions (appetite, pruritus,insomnia)improved, we did not found any adverse effect. Conclusion as a method of MMS clearance, resin hemoperfusion can effectively clean MMS and was confirmed to be a saf and risk-free procedure.
作者 彭艳丽
出处 《中国临床实用医学》 2009年第11期8-10,共3页 China Clinical Practical Medicine
关键词 血液灌流 血液透析 慢性肾功能衰竭 中分子毒素 Hemoperfion Hemodialysis Chronic renal failure Middle moleeuular substances
  • 相关文献

同被引文献10

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部